Latest Platform Technology News

Stakk Limited has reported explosive growth in its SaaS revenue and client base in 2025, positioning itself as a leading embedded finance infrastructure provider. The company’s ARR surged over 300%, driven by major US fintech partnerships and a strategic pivot to a modular SaaS model.

Starpharma has secured a $5.5 million upfront payment from Genentech as part of a new collaboration to develop dendrimer-drug conjugates targeting cancer therapies. The partnership includes potential milestone payments exceeding half a billion dollars and tiered royalties.

Invion Limited has partnered with Protect Animal Health to explore Photosoft™, a novel photodynamic therapy, as a treatment for cancer in companion animals, targeting a booming pet cancer market.

Australian Finance Group Ltd (AFG) reported a robust 21% increase in net profit for FY25, driven by strategic broker network expansion and technology investments, while setting ambitious growth goals through FY29.

Vinyl Group Ltd reports a striking 190% revenue surge in FY25 and a record Q1 FY26, setting sights on its first EBITDA-positive quarter by mid-2026.

PlaySide Studios has extended its development contract with Meta Platforms for Horizon Worlds by 12 months, reinforcing its revenue outlook through 2026.

Streamplay Studio Limited reported a remarkable 201% surge in operating revenue for FY25, driven by its strategic acquisition of Noodlecake Studios and expansion into new markets. Despite a wider operating loss, the company achieved positive cash flow and profitability in the final quarter, signaling a promising turnaround.

Tetratherix Limited advances its Tetramatrix biomaterial platform with a robust IP portfolio, scalable manufacturing, and strategic partnerships aimed at commercialising across multiple clinical franchises.

Tetratherix Limited reports its first financial results as a listed company, revealing a $9.4 million statutory loss driven by R&D and listing costs, alongside a robust $29.3 million cash position post-IPO. The company highlights key operational milestones and outlines strategic plans to accelerate commercialisation across its innovative biomaterial platform.

Tetratherix Limited reported a $9.4 million statutory loss for FY25 amid significant R&D and operational investments, successfully listing on the ASX and progressing multiple clinical and manufacturing initiatives.

Urbanise.com Ltd reported a solid FY2025 with 12.7% growth in Annual Recurring Revenue, underpinned by a strategic partnership with National Australia Bank that includes a 15% equity stake. The company strengthened its cash position and is poised for a new integrated payments solution launch in 2026.

SKS Technologies has reported a remarkable near doubling of revenue to $261.7 million in FY25, driven by strong growth in data centre projects and traditional markets. The company’s robust order book and expanded bank facilities position it well for continued growth in FY26.